date,title,source
Oct-23-18,Oramed to Present at Cardiometabolic Health Congress,PR Newswire
Nov-05-18,Oramed to Present at the Tides Europe 2018 Conference,PR Newswire
Nov-13-18,Oramed Completes Over 50% Randomization in Its Pivotal 90-Day Clinical Study,PR Newswire
Nov-15-18,ORMP: Transferring Coverage; Multiple Clinical Readouts for Oral Protein Delivery Technology Over Next 12-18 Months,Zacks Small Cap Research
Nov-27-18,Is Oramed Pharmaceuticals Incs (NASDAQ:ORMP) CEO Paid Enough Relative To Peers?,Simply Wall St.
Dec-17-18,ORMP: Two Studies Ongoing for ORMD-0801 with Data Readouts in 2019,Zacks Small Cap Research
Jan-09-19,Oramed Receives Additional $3 Million Milestone Payment from HTIT,PR Newswire
Jan-15-19,Oramed Pharmaceuticals' CEO Letter to Shareholders,PR Newswire
